No data to show
XSTO
XPC
Market cap7mUSD
May 23, Last price
0.36SEK
1D
-4.71%
1Q
291.40%
IPO
-90.78%
Name
XP Chemistries AB
Chart & Performance
P/E
—
P/S
254.97
EPS
—
Div Yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
%
Revenues
284k
-57.22%
Net income
-7m
L-11.26%
CFO
-8m
L-15.30%
Profile
XP Chemistries AB, a biotechnology company, develops and produces forest-based capsaicin and analogues. It offers animal feed ingredients, cosmetic ingredients, pure capsaicinoids, and self-defense liquid and ingredients. The company was incorporated in 2018 and is based in Sundsvall, Sweden.
Valuation
Title SEK in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | |
| Income | ||||||
Revenues | 284 -57.22% | 664 -37.14% | 1,056 277.89% | |||
Cost of revenue | (45) | 328 | 567 | |||
Unusual Expense (Income) | ||||||
NOPBT | 329 | 336 | 489 | |||
NOPBT Margin | 115.86% | 50.57% | 46.31% | |||
Operating Taxes | (1,701) | (1,937) | (1,909) | |||
Tax Rate | ||||||
NOPAT | 2,030 | 2,272 | 2,398 | |||
Net income | (7,134) -11.26% | (8,039) 1.55% | (7,917) 74.17% | |||
Dividends | ||||||
Dividend yield | ||||||
Proceeds from repurchase of equity | 2,847 | 4,040 | 5,598 | |||
BB yield | -17.21% | -108.94% | -33.03% | |||
| Debt | ||||||
Debt current | ||||||
Long-term debt | ||||||
Deferred revenue | ||||||
Other long-term liabilities | 888 | |||||
Net debt | (2,145) | (7,827) | (22,459) | |||
| Cash flow | ||||||
Cash from operating activities | (7,694) | (9,083) | (9,853) | |||
CAPEX | (835) | (27) | (1,949) | |||
Cash from investing activities | (835) | (2,328) | (1,949) | |||
Cash from financing activities | 2,847 | 4,040 | 5,598 | |||
FCF | 2,386 | 1,612 | 1,936 | |||
| Balance | ||||||
Cash | 2,145 | 7,827 | 15,198 | |||
Long term investments | 1 | 7,261 | ||||
Excess cash | 2,131 | 7,794 | 22,406 | |||
Stockholders' equity | 4,859 | (15,493) | (9,592) | |||
Invested Capital | 19,434 | 41,181 | 38,641 | |||
ROIC | 6.70% | 5.69% | 6.68% | |||
ROCE | 1.53% | 1.31% | 1.68% | |||
| EV | ||||||
Common stock shares outstanding | 165,373 | 31,163 | 30,931 | |||
Price | 0.10 -15.97% | 0.12 -78.28% | 0.55 -82.27% | |||
Market cap | 16,537 345.94% | 3,708 -78.12% | 16,950 -64.32% | |||
EV | 14,392 | (4,119) | (5,509) | |||
EBITDA | 1,741 | 1,502 | 1,844 | |||
EV/EBITDA | 8.26 | |||||
Interest | 32 | |||||
Interest/NOPBT | 6.55% | |||||